Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Peginesatide> ?p ?o. }
Showing items 1 to 48 of
48
with 100 items per page.
- Peginesatide abstract "Peginesatide (INN/USAN, trade name Omontys, formerly Hematide), developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin. It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis. On February 23, 2013, Affymax and Takeda issued a press release indicating that they were recalling all batches of peginesatide from the market.Two randomized controlled trials published in 2013 found that the effectiveness of peginesatide was not inferior to epoetin for patients receiving dialysis (the EMERALD study), or to darbepoetin for patients with chronic kidney disease who were not receiving dialysis (the PEARL study). However, the safety endpoint of cardiovascular events and death was worse for peginesatide than for darbepoetin in the PEARL study.".
- Peginesatide atcPrefix "B03".
- Peginesatide atcSuffix "XA04".
- Peginesatide casNumber "913976-27-9".
- Peginesatide casSupplemental "(acetate)".
- Peginesatide chEBI "66889".
- Peginesatide iupacName "Poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy-, diester with 21N6,21'N6-{[(N2,N6-dicarboxy-(L)-lysyl-β-alanyl)imino]bis(1-oxo-2,1-ethanediyl)}bis[N-acetylglycylglycyl-(L)-leucyl-(L)-tyrosyl-(L)-alanyl-(L)-cysteinyl-(L)-histidyl-(L)-methionylglycyl-(L)-prolyl-(L)-isoleucyl-(L)-threonyl-3-(1-naphthalenyl)-(L)-alanyl-(L)-valyl-(L)-cysteinyl-(L)-glutaminyl-(L)-prolyl-(L)-leucyl-(L)-arginyl-N-methylglycyl-(L)-lysinamide] cyclic (6→15),(6'→15')-bis(disulfide)".
- Peginesatide wikiPageExternalLink london-2012-holding-back-the-hematide.
- Peginesatide wikiPageID "33989971".
- Peginesatide wikiPageRevisionID "604281993".
- Peginesatide atcPrefix "B03".
- Peginesatide atcSuffix "XA04".
- Peginesatide casNumber "913976".
- Peginesatide chebi "66889".
- Peginesatide chemicalFormula "C231H350N62O58S6[C2H4O]n".
- Peginesatide chemspiderid "NA".
- Peginesatide hasPhotoCollection Peginesatide.
- Peginesatide iupacName "Poly, α-hydro-ω-methoxy-, diester with 21N6,21'N6-{[imino]bis}bis[N-acetylglycylglycyl-(L)-leucyl-(L)-tyrosyl-(L)-alanyl-(L)-cysteinyl-(L)-histidyl-(L)-methionylglycyl-(L)-prolyl-(L)-isoleucyl-(L)-threonyl-3--(L)-alanyl-(L)-valyl-(L)-cysteinyl-(L)-glutaminyl-(L)-prolyl-(L)-leucyl-(L)-arginyl-N-methylglycyl-(L)-lysinamide] cyclic ,-bis".
- Peginesatide legalUs "Rx-only".
- Peginesatide licenceUs "OMONTYS".
- Peginesatide molecularWeight "45".
- Peginesatide pregnancyUs "C".
- Peginesatide pubchemsubstance "124490628".
- Peginesatide routesOfAdministration Intravenous_therapy.
- Peginesatide routesOfAdministration Subcutaneous_tissue.
- Peginesatide tradename "Omontys".
- Peginesatide subject Category:Antianemic_preparations.
- Peginesatide subject Category:Withdrawn_drugs.
- Peginesatide type Abstraction100002137.
- Peginesatide type Act100030358.
- Peginesatide type Activity100407535.
- Peginesatide type AntianemicPreparations.
- Peginesatide type Event100029378.
- Peginesatide type Preparation101143040.
- Peginesatide type PsychologicalFeature100023100.
- Peginesatide type YagoPermanentlyLocatedEntity.
- Peginesatide type Drug.
- Peginesatide type FunctionalSubstance.
- Peginesatide comment "Peginesatide (INN/USAN, trade name Omontys, formerly Hematide), developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin. It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.".
- Peginesatide label "Peginesatide".
- Peginesatide label "Péginésatide".
- Peginesatide sameAs Péginésatide.
- Peginesatide sameAs m.0hrgpdn.
- Peginesatide sameAs Q3662569.
- Peginesatide sameAs Q3662569.
- Peginesatide sameAs Peginesatide.
- Peginesatide wasDerivedFrom Peginesatide?oldid=604281993.
- Peginesatide isPrimaryTopicOf Peginesatide.